Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

Chitosan oligosaccharides (COS) display various biological activities. In this study, we aimed to explore the preventive effects of COS on glucolipid metabolism disorder using palmitic acid (PA)-induced HepG2 cells and high-fat diet (HFD)-fed C57BL/6J mice as experimental models in vitro and in vivo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mar Drugs
Main Authors: Bai, Yibo, Zheng, Junping, Yuan, Xubing, Jiao, Siming, Feng, Cui, Du, Yuguang, Liu, Hongtao, Zheng, Lanyan
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6265870/
https://ncbi.nlm.nih.gov/pubmed/30463189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/md16110455
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados